While conventional neurology may focus on symptom suppression, functional labs like those offered by Vibrant Wellness can help identify modifiable drivers in these areas.
ALS often involves a combination of:
- Mitochondrial dysfunction
- Glutamate excitotoxicity
- Oxidative stress
- Neuroinflammation
- Environmental toxicant exposure
- Nutrient imbalances
- Genetic/epigenetic vulnerabilities
None of these tests will diagnose ALS or reverse it — but they can uncover imbalances that may be accelerating progression or adding to the patient’s burden, and potentially improve quality of life when addressed.
1. Neural Zoomer
- Purpose: Screens for neural-specific autoantibodies and inflammatory triggers.
- What to look for:
- Autoantibodies against neurofilament proteins, myelin basic protein (MBP), and synaptic components
- Markers of blood-brain barrier integrity (e.g., S100B, occludin)
- Glutamate receptor antibodies (important in excitotoxicity)
- Why it matters: If neuroinflammation or autoimmunity is a component in this patient’s ALS phenotype, Neural Zoomer may reveal ongoing immune activity that could be modified (e.g., via immune modulation, diet, etc.).
2. Nutrient Zoomer
- Purpose: Identifies deficiencies in vitamins, minerals, antioxidants, amino acids, and fatty acids.
- Key nutrients of interest in ALS:
- B vitamins, especially B1, B6, B12 (neurotransmitter function & myelination)
- Vitamin D, Vitamin E (antioxidants)
- Magnesium, Zinc, Selenium (neuroprotection, glutathione synthesis)
- CoQ10, L-carnitine, Glutathione (mitochondrial health)
- Omega-3/6 ratios (anti-inflammatory signaling)
3. Toxin Zoomer
- Purpose: Screens for exposure to environmental toxicants that may be neurotoxic.
- Key categories:
- Heavy metals (lead, mercury, aluminum)
- Persistent organic pollutants (e.g., pesticides)
- Mold-related mycotoxins
- Why it matters: There is evidence linking toxicant exposure to neurodegeneration, and ALS patients often have reduced detoxification capacity.
4. Gut Zoomer or Cellular Zoomer
- Rationale: The gut-brain axis is increasingly recognized in neurodegenerative disease.
- Key markers:
- Yeast/fungal overgrowth
- Dysbiosis and lipopolysaccharide (LPS)
- Short-chain fatty acid production (e.g., butyrate)
- Intestinal permeability markers
- Why it matters: Chronic GI inflammation and endotoxemia can increase neuroinflammation.
5. Methylation Genetics
- Purpose: Evaluate genetic vulnerabilities in methylation (e.g., MTHFR, COMT).
- Why it matters: Epigenetics can guide personalized interventions.